Literature DB >> 27578435

Structure, Function, and Evolution of Coronavirus Spike Proteins.

Fang Li1.   

Abstract

The coronavirus spike protein is a multifunctional molecular machine that mediates coronavirus entry into host cells. It first binds to a receptor on the host cell surface through its S1 subunit and then fuses viral and host membranes through its S2 subunit. Two domains in S1 from different coronaviruses recognize a variety of host receptors, leading to viral attachment. The spike protein exists in two structurally distinct conformations, prefusion and postfusion. The transition from prefusion to postfusion conformation of the spike protein must be triggered, leading to membrane fusion. This article reviews current knowledge about the structures and functions of coronavirus spike proteins, illustrating how the two S1 domains recognize different receptors and how the spike proteins are regulated to undergo conformational transitions. I further discuss the evolution of these two critical functions of coronavirus spike proteins, receptor recognition and membrane fusion, in the context of the corresponding functions from other viruses and host cells.

Entities:  

Keywords:  coronavirus spike protein; membrane fusion; postfusion conformation; prefusion conformation; receptor binding; virus evolution; virus origin

Mesh:

Substances:

Year:  2016        PMID: 27578435      PMCID: PMC5457962          DOI: 10.1146/annurev-virology-110615-042301

Source DB:  PubMed          Journal:  Annu Rev Virol        ISSN: 2327-056X            Impact factor:   10.431


  151 in total

1.  Cross-host evolution of severe acute respiratory syndrome coronavirus in palm civet and human.

Authors:  Huai-Dong Song; Chang-Chun Tu; Guo-Wei Zhang; Sheng-Yue Wang; Kui Zheng; Lian-Cheng Lei; Qiu-Xia Chen; Yu-Wei Gao; Hui-Qiong Zhou; Hua Xiang; Hua-Jun Zheng; Shur-Wern Wang Chern; Feng Cheng; Chun-Ming Pan; Hua Xuan; Sai-Juan Chen; Hui-Ming Luo; Duan-Hua Zhou; Yu-Fei Liu; Jian-Feng He; Peng-Zhe Qin; Ling-Hui Li; Yu-Qi Ren; Wen-Jia Liang; Ye-Dong Yu; Larry Anderson; Ming Wang; Rui-Heng Xu; Xin-Wei Wu; Huan-Ying Zheng; Jin-Ding Chen; Guodong Liang; Yang Gao; Ming Liao; Ling Fang; Li-Yun Jiang; Hui Li; Fang Chen; Biao Di; Li-Juan He; Jin-Yan Lin; Suxiang Tong; Xiangang Kong; Lin Du; Pei Hao; Hua Tang; Andrea Bernini; Xiao-Jing Yu; Ottavia Spiga; Zong-Ming Guo; Hai-Yan Pan; Wei-Zhong He; Jean-Claude Manuguerra; Arnaud Fontanet; Antoine Danchin; Neri Niccolai; Yi-Xue Li; Chung-I Wu; Guo-Ping Zhao
Journal:  Proc Natl Acad Sci U S A       Date:  2005-02-04       Impact factor: 11.205

2.  Difference in virus-binding activity of two distinct receptor proteins for mouse hepatitis virus.

Authors:  N Ohtsuka; Y K Yamada; F Taguchi
Journal:  J Gen Virol       Date:  1996-08       Impact factor: 3.891

3.  Crystal structure of mouse coronavirus receptor-binding domain complexed with its murine receptor.

Authors:  Guiqing Peng; Dawei Sun; Kanagalaghatta R Rajashankar; Zhaohui Qian; Kathryn V Holmes; Fang Li
Journal:  Proc Natl Acad Sci U S A       Date:  2011-06-13       Impact factor: 11.205

Review 4.  The carcinoembryonic antigen (CEA) family: structures, suggested functions and expression in normal and malignant tissues.

Authors:  S Hammarström
Journal:  Semin Cancer Biol       Date:  1999-04       Impact factor: 15.707

5.  Mutational analysis of aminopeptidase N, a receptor for several group 1 coronaviruses, identifies key determinants of viral host range.

Authors:  Sonia M Tusell; Stephanie A Schittone; Kathryn V Holmes
Journal:  J Virol       Date:  2006-11-08       Impact factor: 5.103

6.  Identification of residues in the receptor-binding domain (RBD) of the spike protein of human coronavirus NL63 that are critical for the RBD-ACE2 receptor interaction.

Authors:  Han-Xin Lin; Yan Feng; Gillian Wong; Liping Wang; Bei Li; Xuesen Zhao; Yan Li; Fiona Smaill; Chengsheng Zhang
Journal:  J Gen Virol       Date:  2008-04       Impact factor: 3.891

7.  Genetic characterization of Betacoronavirus lineage C viruses in bats reveals marked sequence divergence in the spike protein of pipistrellus bat coronavirus HKU5 in Japanese pipistrelle: implications for the origin of the novel Middle East respiratory syndrome coronavirus.

Authors:  Susanna K P Lau; Kenneth S M Li; Alan K L Tsang; Carol S F Lam; Shakeel Ahmed; Honglin Chen; Kwok-Hung Chan; Patrick C Y Woo; Kwok-Yung Yuen
Journal:  J Virol       Date:  2013-05-29       Impact factor: 5.103

Review 8.  Receptor recognition and cross-species infections of SARS coronavirus.

Authors:  Fang Li
Journal:  Antiviral Res       Date:  2013-08-29       Impact factor: 5.970

9.  Angiotensin-converting enzyme 2 (ACE2) proteins of different bat species confer variable susceptibility to SARS-CoV entry.

Authors:  Yuxuan Hou; Cheng Peng; Meng Yu; Yan Li; Zhenggang Han; Fang Li; Lin-Fa Wang; Zhengli Shi
Journal:  Arch Virol       Date:  2010-06-22       Impact factor: 2.574

10.  SARS coronavirus, but not human coronavirus NL63, utilizes cathepsin L to infect ACE2-expressing cells.

Authors:  I-Chueh Huang; Berend Jan Bosch; Fang Li; Wenhui Li; Kyoung Hoa Lee; Sorina Ghiran; Natalya Vasilieva; Terence S Dermody; Stephen C Harrison; Philip R Dormitzer; Michael Farzan; Peter J M Rottier; Hyeryun Choe
Journal:  J Biol Chem       Date:  2005-12-08       Impact factor: 5.157

View more
  870 in total

Review 1.  COVID-19 and possible links with Parkinson's disease and parkinsonism: from bench to bedside.

Authors:  David Sulzer; Angelo Antonini; Valentina Leta; Anna Nordvig; Richard J Smeyne; James E Goldman; Osama Al-Dalahmah; Luigi Zecca; Alessandro Sette; Luigi Bubacco; Olimpia Meucci; Elena Moro; Ashley S Harms; Yaqian Xu; Stanley Fahn; K Ray Chaudhuri
Journal:  NPJ Parkinsons Dis       Date:  2020-08-20

2.  Immunogenicity and structures of a rationally designed prefusion MERS-CoV spike antigen.

Authors:  Jesper Pallesen; Nianshuang Wang; Kizzmekia S Corbett; Daniel Wrapp; Robert N Kirchdoerfer; Hannah L Turner; Christopher A Cottrell; Michelle M Becker; Lingshu Wang; Wei Shi; Wing-Pui Kong; Erica L Andres; Arminja N Kettenbach; Mark R Denison; James D Chappell; Barney S Graham; Andrew B Ward; Jason S McLellan
Journal:  Proc Natl Acad Sci U S A       Date:  2017-08-14       Impact factor: 11.205

3.  Neutralizing nanobodies bind SARS-CoV-2 spike RBD and block interaction with ACE2.

Authors:  Jiandong Huo; Audrey Le Bas; Reinis R Ruza; Helen M E Duyvesteyn; Halina Mikolajek; Tomas Malinauskas; Tiong Kit Tan; Pramila Rijal; Maud Dumoux; Philip N Ward; Jingshan Ren; Daming Zhou; Peter J Harrison; Miriam Weckener; Daniel K Clare; Vinod K Vogirala; Julika Radecke; Lucile Moynié; Yuguang Zhao; Javier Gilbert-Jaramillo; Michael L Knight; Julia A Tree; Karen R Buttigieg; Naomi Coombes; Michael J Elmore; Miles W Carroll; Loic Carrique; Pranav N M Shah; William James; Alain R Townsend; David I Stuart; Raymond J Owens; James H Naismith
Journal:  Nat Struct Mol Biol       Date:  2020-07-13       Impact factor: 15.369

4.  Mouse-adapted MERS coronavirus causes lethal lung disease in human DPP4 knockin mice.

Authors:  Kun Li; Christine L Wohlford-Lenane; Rudragouda Channappanavar; Jung-Eun Park; James T Earnest; Thomas B Bair; Amber M Bates; Kim A Brogden; Heather A Flaherty; Tom Gallagher; David K Meyerholz; Stanley Perlman; Paul B McCray
Journal:  Proc Natl Acad Sci U S A       Date:  2017-03-27       Impact factor: 11.205

5.  Fundamental evolution of all Orthocoronavirinae including three deadly lineages descendent from Chiroptera-hosted coronaviruses: SARS-CoV, MERS-CoV and SARS-CoV-2.

Authors:  Denis Jacob Machado; Rachel Scott; Sayal Guirales; Daniel A Janies
Journal:  Cladistics       Date:  2021-04-26       Impact factor: 5.254

6.  Impact of COVID-19: perspectives from gastroenterology.

Authors:  Shu Wen Tay; Kevin Kim Jun Teh; Lai Mun Wang; Tiing Leong Ang
Journal:  Singapore Med J       Date:  2020-04-13       Impact factor: 1.858

Review 7.  Advances in the possible treatment of COVID-19: A review.

Authors:  Pankaj Chibber; Syed Assim Haq; Irfan Ahmed; Nusrit Iqbal Andrabi; Gurdarshan Singh
Journal:  Eur J Pharmacol       Date:  2020-07-17       Impact factor: 4.432

8.  Preparatory phase for clinical trials of COVID-19 vaccine in Nepal.

Authors:  Govind Prasad Gupta; Yogendra Shah; Dhan Kumar Pant; Sunil Lekhak; Ramesh Shahi; Ananda Mandal; Pramod Poudel; Shayam Prakash Dumre; Kishor Pandey; Basu Dev Pandey
Journal:  Hum Vaccin Immunother       Date:  2020-09-23       Impact factor: 3.452

Review 9.  Epigenetic mechanisms regulating COVID-19 infection.

Authors:  Sarantis Chlamydas; Athanasios G Papavassiliou; Christina Piperi
Journal:  Epigenetics       Date:  2020-07-30       Impact factor: 4.528

Review 10.  Molecular biology of coronaviruses: current knowledge.

Authors:  I Made Artika; Aghnianditya Kresno Dewantari; Ageng Wiyatno
Journal:  Heliyon       Date:  2020-08-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.